HYPERCALCEMIC HYPERPARATHYROID CRISIS
https://doi.org/10.21292/2078-5658-2019-16-3-55-62
Abstract
Hypercalcemic hyperparathyroid crisis is a rare and potentially life threatening manifestation of primary hyperparathyroidism. The article describes a clinical case of a 66-year old female patient who developed hypercalcemic hyperparathyroid crisis after neurosurgical intervention. Computed tomography used for targeted diagnostics detected parathyroid adenoma of the ectopic localization. The conservative therapy failed and the surgery was indicated - thoracoscopic excision of adenoma. This clinical case illustrates the contemporary approaches to diagnostics and management of this disorder.
About the Authors
E. G. GАVRILOVА
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
Elena G. Gavrilova
Candidate of Medical Sciences, Associate Professor of Anesthesiology and Intensive Care Department, Head of Anesthesiology and Intensive /Care Department no. 2 of Research Clinical Center of Anesthesiology and Intensive Care.
6-8, Lva Tolstogo St., St. Petersburg, 197022
K. N. KHRАPOV
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
Kirill N. Khrapov
Doctor of Medical Sciences, Professor of Anesthesiology and Intensive Care Department, Head of Anesthesiology Department of Research Clinical Center of Anaesthesiology and Intensive Care.
6-8, Lva Tolstogo St., St. Petersburg, 197022
References
1. Barman Balfour J.A., Scott L.J. Cinacalcet hydrochloride. Drugs, 2005, vol. 65, no. 2, pp. 271‒281.
2. Binstock M.L., Mundy G.R. Effect of calcitonin and glutocorticoids in combination on the hypercalcemia of malignancy. Ann. Intern. Med., 1980, vol. 93, no. 2, pp. 269‒272.
3. Cannon J., Lew J.I., Solorzano C.C. Parathyroidectomy for hypercalcemic crisis: 40 years’ experience and long-term out-comes. Surgery, 2010, vol. 148, no. 4, pp. 807‒812, discussion 812‒813.
4. Collip J.P., Clarke E.P., Scott J.W. Effect of parathyroid hormone on nor-mal animals. J. Biol. Chem., 1925, vol. 63, pp. 439.
5. Dawson J.W., Struthers J.W. Generalized Osteitis fibrosa with parathyroid tumor and metastatic calcification. Edinburgh Med. J., 1923, vol. 30, pp. 421.
6. Edelson G.W., Kleerekoper M. Hypercalcemic crisis. Med. Clin. North Am., 1995, vol. 79, no. 1, pp. 79‒92.
7. Fraser W. Hyperparathyroidsm. Lancet, 2009, vol. 374, pp. 145-158.
8. Heller S.R., Hosking D.J. Renal handling of calcium and sodium in metastatic and non-metastatic malignancy. Br. Med. J., 1986, vol. 292(6520), pp. 583‒586.
9. Hosking D.J., Cowley A., Bucknall C.A. Rehy-dration in the the treatment of severe hypercalcaemia. Q. J. Med., 1981, vol. 50, no. 200, pp. 473‒481.
10. Jansson S., Tisell L.E., Lindstedt G. et al. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism. Surgery, 1991, vol. 110, no. 3, pp. 480‒486.
11. Kyle R.A., Yee G.C., Somerfield M.R. et al. American Society of Clinical On-cology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. J. Clin. Oncol., 2007, vol. 25, no. 17, pp. 2464‒2472.
12. Lemann J., Donatelli A.A. Calcium intoxication due to primary hyperparathyroidism: a medical and surgical emergency. Ann. Intern. Med., 1964, vol. 60, pp. 447-461.
13. Lew J.I., Solorzano C.C., Irvin G.L. 3rd. Long-term results of parathyroidectomy for hypercalcemic crisis. Arch. Surg., 2006, vol. 141, no. 7, pp. 696‒699.
14. Lowenberg H., Ginsburg T.M. Acute hypercalcemia: report of a case. JAMA, 1932, vol. 99, pp. 1166.
15. Major P., Lortholary A., Hon J. et al. Zoledronic acid is superior to pamidro-nate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials. J. Clin. Oncol., 2001, vol. 19, no. 2, pp. 558‒567.
16. Nussbaum S.R., Younger J., Vandepol C.J. et al. Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignan-cy: comparison of 30-, 60-, and 90-mg dosages. Am. J. Med., 1993, vol. 95, no. 3, pp. 297‒304.
17. Payne J.E., Tanenberg R.J. Hyperparathyroid crisis and acute necrotizing pancreatitis presenting as diabetic ketoacidosis. Am. J. Surg., 1980, vol. 140, no. 5, pp. 698‒703.
18. Perazella M.A., Markowitz G.S. Bisphosphonate nephrotoxicity. Kidney Int., 2008, vol. 74, no. 11, pp. 1385‒1393.
19. Phitayakorn R., McHenry C.R. Hyperparathyroid crisis: use of bisphospho-nates as a bridge to parathyroidectomy. J. Am. Coll. Surg., 2008, vol. 206, no. 3, pp. 1106‒1115.
20. Ralston S.H., Alzaid A.A., Gardner M.D. et al. Treatment of cancer asso-ciated hypercalcaemia with combined aminohydroxypropylidene diphos-phonate and calcitonin. Br. Med. J. (Clin. Res. Ed.), 1986, vol. 292(6535), pp. 1549‒1550.
21. Ralston S.H., Coleman R., Fraser W.D. et al. Medical management of hypercalcemia. Calcif. Tissue Int., 2004, vol. 74, no. 1, pp. 1‒11.
22. Ralston S.H., Gallacher S.J., Patel U. et al. Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet, 1989, vol. 2(8673), pp. 1180‒1182.
23. Ralston S.H., Gardner M.D., Dryburgh F.J. et al. Comparison of aminohy-droxypropylidene diphosphonate, mithramycin, and corticoster-oids/calcitonin in treatment of cancer-associated hypercalcaemia. Lancet, 1985, vol. 2(8461), pp. 907‒910.
24. Schweitzer V.G., Thompson N.W., Harness J.K. et al. Management of severe hypercalcemia caused by primary hyperparathyroidism. Arch. Surg., 1978, vol. 113, no. 4, pp. 373‒381.
25. Sharma O.P. Hypercalcemia in granulomatous disorders: a clinical review. Curr. Opin. Pulm. Med., 2000, vol. 6, no. 5, pp. 442‒447.
26. Starker L.F., Bjorklund P., Theoharis C. et al. Clinical and histopathological characteristics of hyperparathyroidism-induced hypercalcemic crisis. World. J. Surg., 2011, vol. 35, no. 2, pp. 331‒335.
27. Suki W.N., Yium J.J., Von Minden M. et al. Acute treatment of hypercalcemia with furosemide. N. Engl. J. Med., 1970, vol. 283, no. 16, pp. 836‒840.
28. Thiebaud D., Jacquet A.F., Burckhardt P. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate. Arch. Intern. Med., 1990, vol. 150, no. 10, pp. 2125‒2128.
29. Wang C.A., Guyton S.W. Hyperparathyroid crisis: clinical and pathologic studies of 14 patients. Ann. Surg., 1979, vol. 190, no. 6, pp. 782‒790.
30. Wong P., Carmeci C., Jeffrey R. B. et al. Parathyroid crisis in a 20 year old ‒ an unusual cause of hypercalcaemic crisis. Postgrad. Med. J., 2001, vol. 77(909), pp. 468‒470.
31. Ziegler R. Hypercalcemic crisis. J. Am. Soc. Nephrol., 2001, 12, pp. S3–S9.
Review
For citations:
GАVRILOVА E.G., KHRАPOV K.N. HYPERCALCEMIC HYPERPARATHYROID CRISIS. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2019;16(3):55-62. (In Russ.) https://doi.org/10.21292/2078-5658-2019-16-3-55-62
Email this article 